Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Price History
|
Ratios
|
Insiders
Bullboard - Stock Discussion Forum
Antibe Therapeutics Inc(Pre-Merger)
ATBPF
Healthcare
Biotechnology
Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,...
otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Bullboard (OTCID:ATBPF)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(1)
•••
Cstocks90
X
Post by
Cstocks90
on Apr 25, 2024 5:35pm
Bag hold
I've bag held this thing for years, the Arbitration ruling was a dagger, other than that I thought we were on a good track. Expensive lesson, lick your wounds gneltemen. glta yolo
(33)
•••
Inthepez
X
Post by
Inthepez
on Apr 25, 2024 2:47pm
Can always count on dumpster to
Be a POS
(1566)
•••
Duster340
X
Post by
Duster340
on Apr 25, 2024 11:34am
Sad to see
ATE going away, there was more money to be made, lots more. had they been able to finish P2 and if it would have been successful $$$. this was my biggest cash cow over the last 5 months. i am
...more
(0)
•••
Gessurong
X
Comment by
Gessurong
on Apr 25, 2024 9:47am
RE:Mugsy, want to be wrong all the way to Zero
Hope he is just embarrassed. Rude awakening if he got played like all of us
(1)
•••
ChiChi2
X
Comment by
ChiChi2
on Apr 24, 2024 3:42pm
RE:RE:Germ of a Plan - $20 million USD
So is this the end of it? We can write off our loss and close the book? No more hope?
(15)
•••
SimonSaysLues
X
Post by
SimonSaysLues
on Apr 24, 2024 3:38pm
The the bush pilot landed the plane alright
Mugsy. Haha. Just a minor setback haha. More shares for me hahaha. Loving this. I'm grabbing a boatload at .01. Haha. Where did you go ?
(8)
•••
TechMoose
X
Comment by
TechMoose
on Apr 24, 2024 11:36am
RE:Germ of a Plan - $20 million USD
Some great ideas here MSTRMDS.....Appreciate you putting this together… But the receiver appointment today looks to be a very bad development for the shareholders. I guess "sometimes the
...more
(0)
•••
PressRelease
X
Post by
PressRelease
on Apr 24, 2024 11:15am
New Press Release - Antibe Announces Appointment of Receiver
Antibe Therapeutics Inc. (“Antibe” or the “Company”) (TSX: ATE) announced that the Company’s request for an extension of its previously announced stay of proceedings under the Companies’ Creditors Arrangement Act (the “CCAA”) was heard before the Ontario Superior Court of Justice (Commercial List...
read article.
(15)
•••
SimonSaysLues
X
Post by
SimonSaysLues
on Apr 23, 2024 10:15am
Lol. You think Dan is capable of all that????????
He can't even talk !!!
(17)
•••
mstrmnds
X
Post by
mstrmnds
on Apr 23, 2024 1:09am
Germ of a Plan - $20 million USD
GERM OF A PLAN FOR MADMAN OSBORNE: 1. Citagenix - 1) request sale proceeds early or 2) transfer sale agreement payout to Nuance 2. SRED credits - 1) early filings and urgent request 2) transfer
...more
(15)
•••
SimonSaysLues
X
Post by
SimonSaysLues
on Apr 20, 2024 7:49am
Mugsy, want to be wrong all the way to Zero
You are almost there ProfessorCornelius
(0)
•••
PressRelease
X
Post by
PressRelease
on Apr 19, 2024 8:04am
New Press Release - Antibe Provides Update on CCAA Proceedings
Antibe Therapeutics Inc. (“Antibe” or the “Company”) (TSX: ATE) announced that the Company sought an extension of its previously announced stay of proceedings (“Stay”) under the Companies’ Creditors Arrangement Act (the “CCAA”) at a hearing before the Ontario Superior Court of Justice (Commercial...
read article.
(1566)
•••
Duster340
X
Post by
Duster340
on Apr 16, 2024 8:09pm
RE:RE:RE: I don't know ...
Nuance did not want to delay, clearly they wanted there money back as fast as possible before it is all gone. they lost trust in the snake oil salesman. the old saying comes to mind (fool me once
...more
(0)
•••
Gessurong
X
Comment by
Gessurong
on Apr 16, 2024 7:06pm
RE:I don't know ...
That would probably be illegal to delay a judgement because you think you lost
(3)
•••
Chianchin
X
Comment by
Chianchin
on Apr 16, 2024 5:40pm
RE:I don't know ...
Peacefull is misspeled for painful......ouch ...bla....bla...only left
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
Podcasts